These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 12874820

  • 1. Plasmapheresis in multiple sclerosis.
    McLeod BC.
    J Clin Apher; 2003; 18(2):72-4. PubMed ID: 12874820
    [No Abstract] [Full Text] [Related]

  • 2. [Plasmapheresis in multiple sclerosis].
    Fuchs S, Pogglitsch H, Ladurner G, Lechner H.
    Wien Klin Wochenschr; 1984 Jan 20; 96(2):67-9. PubMed ID: 6710999
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Lymphocyto-plasmapheresis for relapsing multiple sclerosis].
    Jyoichi T, Kamegai M, Noda Y, Shimojo S, Miyahara T.
    Rinsho Shinkeigaku; 1986 Sep 20; 26(9):907-9. PubMed ID: 3791770
    [No Abstract] [Full Text] [Related]

  • 5. [Current therapy of multiple sclerosis. Are there indications for plasmapheresis?].
    Schönbeck S, Hohlfeld R.
    Nervenarzt; 1992 Feb 20; 63(2):116-9. PubMed ID: 1314334
    [No Abstract] [Full Text] [Related]

  • 6. [Use of therapeutic plasmapheresis in the exacerbation period of multiple sclerosis].
    Neretin VIa, Kir'iakova VA, Sapfirova VA, Ivanov MI, Volkova EK.
    Sov Med; 1988 Feb 20; (2):86-9. PubMed ID: 3388103
    [No Abstract] [Full Text] [Related]

  • 7. [Acute and reversible worsening of multiple sclerosis treated with plasmapheresis. A form of Uhthoff symptom?].
    Muchnik S, Jáuregui WO, Mazía C.
    Medicina (B Aires); 1985 Feb 20; 45(2):207-8. PubMed ID: 3841931
    [No Abstract] [Full Text] [Related]

  • 8. Disease modifying therapies in multiple sclerosis.
    Khatri BO, McQuillen MP.
    Neurology; 2002 Aug 13; 59(3):472; author reply 472-3. PubMed ID: 12184316
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evidence-based medicine and multiple sclerosis: figures and stories.
    Kesselring J.
    Neuroepidemiology; 2010 Aug 13; 35(2):100. PubMed ID: 20551695
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Plasmapheresis in acute phase of multiple sclerosis].
    Matsuo H.
    Nihon Rinsho; 2015 Sep 13; 73 Suppl 7():191-5. PubMed ID: 26480699
    [No Abstract] [Full Text] [Related]

  • 15. Multiple sclerosis-like illness in early HIV infection.
    Graber P, Rosenmund A, Probst A, Zimmerli W.
    AIDS; 2000 Oct 20; 14(15):2411-3. PubMed ID: 11089636
    [No Abstract] [Full Text] [Related]

  • 16. [Plasmapheresis in the treatment of nervous system diseases].
    Zaleska B.
    Neurol Neurochir Pol; 1984 Oct 20; 18(5):409-13. PubMed ID: 6527723
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relapse of multiple sclerosis following acute allergic reactions to plasma during plasmapheresis.
    Wirguin I, Shinar E, Abramsky O.
    J Neurol; 1989 Jan 20; 236(1):62-3. PubMed ID: 2915232
    [Abstract] [Full Text] [Related]

  • 20. Plasmapheresis in acute multiple sclerosis: rationale and results.
    Dau PC.
    J Clin Apher; 1991 Jan 20; 6(4):200-4. PubMed ID: 1816240
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.